The report “Global Chemotherapy-Induced Nausea and Vomiting (CINV) & Postoperative Nausea and Vomiting (PONV) Market: Industry Analysis & Outlook (2018-2022)” provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers, key tends & developments and challenges of the market, covering the U.S., Europe along with the global market. The report profiles the key players of the market including Merck & Co., Inc., Kirin Holding Company Limited (ProStrakan), Eisai Co., Ltd. and Helsinn Holding S.A.
Inquire for a discount on this CINV & PONV Market report at http://www.marketreportsonline.com/contacts/discount.php?name=745672.
Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides chemotherapy, there are various types of factors that puts a patient high risk for CINV including female sex, history of alcohol use, CINV & motion sickness and anxiety or depression.
Postoperative Nausea and Vomiting (PONV) is referred to as a situation in which an inpatient experiences nausea and/or vomiting within the first 24-48 hours after undergoing surgery with general anesthesia. The incidence of PONV is 30% in the all post-surgical patients and 80% in high-risk patients. PONV is caused due to various factors including anesthetic choices, patient and surgery-specific. Treatment of PONV is done through prophylaxis and rescue treatment.
Purchase a copy of this research report at USD 1000 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=745672.
The U.S. emerged as a major region for the CINV & PONV market due to rising healthcare concerns and expenditure of the U.S. populace and growing CINV & PONV patient population.
The global CINV & PONV market is expected to grow with increasing cancer incidence, growing female population, increasing pharmaceutical R&D spending, growing healthcare expenditure and accelerating economic growth. Key trends and developments of this market includes progressing drugs under pipeline, high demand for combination therapy and increasing preference for pressure point therapy. However, there are some factors which can hinder growth of the market including entry of generics, stringent regulations and treatment cost.
Few Points from List of Tables & Figures Provided in Global Chemotherapy-Induced Nausea and Vomiting (CINV) & Postoperative Nausea and Vomiting (PONV) Market 2018-2022:
List of Tables
Causes of PONV
Drugs under Development for CINV & PONV
Generics for CINV Therapies (2016-2018)
Key Players – Revenues Comparison (2017)
CINV & PONV Treatment Cost Comparison by Company (2018)
Helsinn Holding S.A. Drug Pipeline (2018)
List of Figures
Sub-Categories of CINV
Global CINV Market Forecast by Value (2017-2022)
Global PONV Market Forecast by Value (2017-2022)
The U.S. CINV & PONV Market Forecast by Value (2017-2022)
The U.S. CINV & PONV Drugs Revenue by Categories (2017)
The U.S. Aloxi Drug Revenue (2013-2017)
The U.S. Aloxi Drug Revenue Forecast (2018-2022)
The U.S. Emend Drug Revenue Forecast (2017-2022)
The U.S. Sustol Drug Revenue Forecast (2017-2022)
The U.S. Cinvanti Drug Revenue Forecast (2018-2022)
The U.S. Varubi Oral Drug Revenue Forecast (2018-2022)
Browse All Latest Pharmaceuticals Market Research Reports at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.
Market Reports Online is a comprehensive online library of more than 100,000 reports, in-depth market research studies on thousands of micro markets and a range of industries. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. We offer online and offline support services to ensure your research requirements are met on time.
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001.
Tel: + 1 888 391 5441